Atypical Mycobacterial Exit-Site Infection and Peritonitis in Peritoneal Dialysis Patients on Prophylactic Exit-Site Gentamicin Cream | Zendy

Lo Man-wai | Zendy; Mak Siu-ka | Zendy; Wong Yuk-yi | Zendy; Lo Kwok-chi | Zendy; Chan Shuk-fan | Zendy; Tong Gensy M.W. | Zendy; Lo Kin-yee | Zendy; Wong Ping-nam | Zendy; Tse Cindy W.S. | Zendy; Kam Kai-man | Zendy; Wong Andrew K.M. | Zendy

Open Access

Atypical Mycobacterial Exit-Site Infection and Peritonitis in Peritoneal Dialysis Patients on Prophylactic Exit-Site Gentamicin Cream

Author(s) -

Lo Man-wai,

Mak Siu-ka,

Wong Yuk-yi,

Lo Kwok-chi,

Chan Shuk-fan,

Tong Gensy M.W.,

Lo Kin-yee,

Wong Ping-nam,

Tse Cindy W.S.,

Kam Kai-man,

Wong Andrew K.M.

Publication year - 2013

Publication title -

peritoneal dialysis international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.79

H-Index - 83

eISSN - 1718-4304

pISSN - 0896-8608

DOI - 10.3747/pdi.2011.00184

Subject(s) - medicine , peritoneal dialysis , peritonitis , gentamicin , continuous ambulatory peritoneal dialysis , exit site , antibiotics , surgery , microbiology and biotechnology , biology

We report 9 cases of exit-site infection and continuous ambulatory peritoneal dialysis peritonitis associated with atypical mycobacteria. All patients had been using topical gentamicin cream as prophylaxis for exit-site infection before the onset of these infections. Gentamicin cream is postulated to be a potential risk factor for atypical mycobacterial infection because of selective pressure on other micro-organisms. The microbiology of atypical mycobacteria and the treatment for atypical mycobacterial infections are discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research